Stay updated on Durvalumab in Cervical Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab in Cervical Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab in Cervical Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The study record for the completed CALLA Phase III trial is available, with details about durvalumab plus chemoradiotherapy for locally advanced cervical cancer, eligibility, study outcomes, and results-related resources.
    Difference
    97%
    Check dated 2026-11-10T15:09:23.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T15:57:02.000Z thumbnail image
  3. Check
    24 days ago
    Change Detected
    Summary
    A sitewide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page. The ClinicalTrials.gov revision number changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T18:35:54.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.0 to v3.7.1 while the study record page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-06T18:56:18.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The CALLA study record page now displays a 403 Forbidden error, indicating that access to the study content is blocked.
    Difference
    17%
    Check dated 2026-09-22T22:12:20.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.7.0 replacing the previous v3.6.6, indicating a new deployment/build of the site. This appears to be a maintenance/versioning change rather than an update to study details or user-facing actions.
    Difference
    0.0%
    Check dated 2026-09-15T22:15:36.000Z thumbnail image

Stay in the know with updates to Durvalumab in Cervical Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab in Cervical Cancer Clinical Trial page.